155 related articles for article (PubMed ID: 377597)
1. Enhancing alloantibody effective during sensitization but not effector phase of skin graft rejection.
Sugarbaker PH; Chang AE
Transplantation; 1979 Jul; 28(1):60-5. PubMed ID: 377597
[No Abstract] [Full Text] [Related]
2. Abrogation of T cell homing by alloantibody.
Chang AE; Sugarbaker PH
Transplantation; 1980 Feb; 29(2):127-32. PubMed ID: 6986686
[TBL] [Abstract][Full Text] [Related]
3. Effect of alloantibodies on corneal allograft survival.
Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
[TBL] [Abstract][Full Text] [Related]
4. Diminished cellular cytotoxicity in mice hyperimmunized prior to skin grafting.
Sugarbaker PH
Cell Immunol; 1981 Jan; 57(1):99-113. PubMed ID: 6783318
[No Abstract] [Full Text] [Related]
5. Studies of alloantibody effect on skin graft survival in mice.
Dohi K; Asahara T; Ono E; Yahata H; Fukuda Y
Hiroshima J Med Sci; 1984 Jun; 33(2):271-4. PubMed ID: 6384147
[No Abstract] [Full Text] [Related]
6. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
[TBL] [Abstract][Full Text] [Related]
7. Induced immune destruction of long-surviving, H-2 incompatible kidney transplants in mice.
Russell PS; Chase CM; Colvin RB; Plate JM
J Exp Med; 1978 May; 147(5):1469-86. PubMed ID: 349112
[No Abstract] [Full Text] [Related]
8. Suppression of rejection of organ allografts by alloantibody.
Morris PJ
Immunol Rev; 1980; 49():93-125. PubMed ID: 6445324
[No Abstract] [Full Text] [Related]
9. Transfer of cell-mediated hyperacute rejection reaction. The role of active sensitization.
Emam M; Barstad R; Eichwald EJ
Cell Immunol; 1980 Feb; 49(2):426-31. PubMed ID: 6986205
[No Abstract] [Full Text] [Related]
10. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
[TBL] [Abstract][Full Text] [Related]
11. Immune serum implements either accelerated rejection or prolonged survival of murine skin grafts.
Baldwin WM; Cohen N
Transplantation; 1973 Jun; 15(6):633-7. PubMed ID: 4577160
[No Abstract] [Full Text] [Related]
12. CD4+ T-cell-dependent immune damage of liver parenchymal cells is mediated by alloantibody.
Horne PH; Lunsford KE; Eiring AM; Wang Y; Gao D; Bumgardner GL
Transplantation; 2005 Aug; 80(4):514-21. PubMed ID: 16123727
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of skin allograft survival by soluble alloantigen is serum-mediated.
Rao VS; Bonavida B
Transplantation; 1976 Jan; 21(1):42-50. PubMed ID: 1108325
[TBL] [Abstract][Full Text] [Related]
14. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
Freedman LR; Cerottini JC; Brunner KT
J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
[No Abstract] [Full Text] [Related]
15. In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor.
Rosenstein M; Eberlein T; Kemeny MM; Sugarbaker PH; Rosenberg SA
J Immunol; 1981 Aug; 127(2):566-71. PubMed ID: 7019327
[TBL] [Abstract][Full Text] [Related]
16. The use of an anti-CD3 priming dose to enhance the immunosuppressive potency of monoclonal and polyclonal T-cell antisera.
Sherburne CG; Onyekaba CO; Condie RM
Transplant Proc; 1991 Feb; 23(1 Pt 1):626-9. PubMed ID: 1824996
[No Abstract] [Full Text] [Related]
17. Presence of circulating anti-H-2 antibody and cell-mediated precursors in successful DBA/2J-plus-(DBA/2J X C3H/HeJ)F1 parabiosed mice.
Drell DW; Carlson GA; Wegmann TG
J Immunol; 1979 Nov; 123(5):2319-27. PubMed ID: 385781
[No Abstract] [Full Text] [Related]
18. Uncovered skin grafts in mice.
Sugarbaker PH; Chang AE
J Immunol Methods; 1979; 31(1-2):167-75. PubMed ID: 390055
[TBL] [Abstract][Full Text] [Related]
19. Short-term MyD88 inhibition ameliorates cardiac graft rejection and promotes donor-specific hyporesponsiveness of skin grafts in mice.
He WT; Zhang LM; Li C; Li SY; Ding ZC; Fang ZM; Meng FY; Chen ZK; Zhou P
Transpl Int; 2016 Aug; 29(8):941-52. PubMed ID: 27125343
[TBL] [Abstract][Full Text] [Related]
20. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.
Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL
Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
